Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2004

View Archived Issues

Single and dual GSK-3/PKC inhibitors prepared and tested at Janssen

New HCV NS3 protease inhibitors under study at BMS

Millennium claims the preparation and use of chemokine CCR9 antagonists

Two novel series of HDAC inhibitors discovered at Beacon

Novartis identifies aliskiren-related renin inhibitors as antihypertensive agents

New SGLT2 inhibitor for use in type 2 diabetes covered by BMS patent

Pliva researchers design two series of TNF-alpha/IL-1 production inhibitors

Tigecycline is effective against Staphylococcus epidermis biofilms

ViaCell announces collaboration with Amgen

Pfizer and Akzo Nobel's Organon collaboration moves forward

Merger of Novuspharma into Cell Therapeutics completed

Tentative approval for Sicor's fluconazole aNDA

Symlin marketing application withdrawn in Switzerland

Aventis and Crucell enter PER.C6 agreement for novel influenza vaccines

University of Rochester to study rhIGF-I/rhIGFBP-3 for myotonic dystrophy

Keryx to acquire Access Oncology

New small molecule collaboration between Infinity and Amgen

Biopure and the FDA discuss complete response letter for Hemopure BLA

ImmunoGen to advance TAP compounds into proof-of-concept trials

Pain Therapeutics announces H1 2004 milestones

Paladin to market Watson's Oxytrol in Canada

Hemispherx Biopharma accelerates SARS program

NCX-4016 reaches primary efficacy endpoint in phase IIa PAOD study

UroGene to develop besipirdine for overactive bladder

Perlegen and Pfizer collaborate on metabolic syndrome research

Palonosetron reported safe and more effective than ondansetron against CINV

Lipid-lowering effects of lovastatin and a diet containing cholesterol-lowering foods

Attenuated inflammatory response to sepsis found with N-acetylcysteine

Anticoagulant protein rNAPc2 increases survival of rhesus macaques infected with Ebola virus

Improved antibiotic activity of novel desmycosin analogues described

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...